Follow
Shawn Kwatra, MD
Shawn Kwatra, MD
Associate Professor of Dermatology and Oncology, Johns Hopkins Hospital
Verified email at jhmi.edu - Homepage
Title
Cited by
Cited by
Year
Real-world prevalence of prurigo nodularis and burden of associated diseases
AH Huang, JK Canner, R Khanna, S Kang, SG Kwatra
The Journal of investigative dermatology 140 (2), 480-483. e4, 2020
1342020
Ethnic differences and comorbidities of 909 prurigo nodularis patients
E Boozalis, O Tang, S Patel, YR Semenov, MP Pereira, S Stander, S Kang, ...
Journal of the American Academy of Dermatology 79 (4), 714-719. e3, 2018
1292018
Gabapentin and pregabalin for the treatment of chronic pruritus
KM Matsuda, D Sharma, AR Schonfeld, SG Kwatra
Journal of the American Academy of Dermatology 75 (3), 619-625. e6, 2016
1142016
Prurigo nodularis: epidemiology and clinical features
AH Huang, KA Williams, SG Kwatra
Journal of the American Academy of Dermatology 83 (6), 1559-1565, 2020
1082020
Dermatology practices as vectors for COVID-19 transmission: a call for immediate cessation of nonemergent dermatology visits
SG Kwatra, RJ Sweren, AL Grossberg
Journal of the American Academy of Dermatology 82 (5), e179-e180, 2020
1062020
Comparative efficacy of biologics in psoriasis: a review
IH Kim, CE West, SG Kwatra, SR Feldman, JL O’Neill
American journal of clinical dermatology 13, 365-374, 2012
1042012
A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor‐mediated apoptosis in glioblastomas
T Akazawa, SG Kwatra, LE Goldsmith, MD Richardson, EA Cox, ...
Journal of neurochemistry 109 (4), 1079-1086, 2009
1032009
Prurigo nodularis: pathogenesis and management
KA Williams, AH Huang, M Belzberg, SG Kwatra
Journal of the American Academy of Dermatology 83 (6), 1567-1575, 2020
992020
Identification of a bilirubin receptor that may mediate a component of cholestatic itch
J Meixiong, C Vasavda, D Green, Q Zheng, L Qi, SG Kwatra, JP Hamilton, ...
Elife 8, e44116, 2019
972019
Practical approaches for diagnosis and management of prurigo nodularis: United States expert panel consensus
S Elmariah, B Kim, T Berger, S Chisolm, SG Kwatra, N Mollanazar, ...
Journal of the American Academy of Dermatology 84 (3), 747-760, 2021
962021
Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis
KA Williams, YS Roh, I Brown, N Sutaria, P Bakhshi, J Choi, S Gabriel, ...
Expert Review of Clinical Pharmacology 14 (1), 67-77, 2021
892021
A multidisciplinary toxicity team for cancer immunotherapy–related adverse events
J Naidoo, J Zhang, EJ Lipson, PM Forde, K Suresh, KF Moseley, S Mehta, ...
Journal of the National Comprehensive Cancer Network 17 (6), 712-720, 2019
822019
Cannabinoids for the treatment of chronic pruritus: A review
C Avila, S Massick, BH Kaffenberger, SG Kwatra, M Bechtel
Journal of the American Academy of Dermatology 82 (5), 1205-1212, 2020
762020
Association of cutaneous immune-related adverse events with increased survival in patients treated with anti–programmed cell death 1 and anti–programmed cell death ligand 1 therapy
K Tang, J Seo, BC Tiu, TK Le, V Pahalyants, NS Raval, PO Ugwu-Dike, ...
JAMA dermatology 158 (2), 189-193, 2022
722022
Female-specific pruritus from childhood to postmenopause: clinical features, hormonal factors, and treatment considerations
LP Rimoin, G Yosipovitch, M McKay
Skin, Mucosa and Menopause: Management of Clinical Issues, 111-124, 2014
692014
Breaking the itch–scratch cycle in prurigo nodularis
SG Kwatra
New England Journal of Medicine 382 (8), 757-758, 2020
672020
Prurigo nodularis is characterized by systemic and cutaneous T helper 22 immune polarization
M Belzberg, MP Alphonse, I Brown, KA Williams, R Khanna, B Ho, ...
Journal of Investigative Dermatology 141 (9), 2208-2218. e14, 2021
642021
Quality of life in family members of vitiligo patients: a questionnaire study in Saudi Arabia
GA Bin Saif, AO Al-Balbeesi, R Binshabaib, D Alsaad, SG Kwatra, ...
American journal of clinical dermatology 14, 489-495, 2013
642013
Aprepitant for the treatment of chronic refractory pruritus
A He, JM Alhariri, RJ Sweren, MM Kwatra, SG Kwatra
BioMed research international 2017, 2017
622017
Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis
S Wongvibulsin, V Pahalyants, M Kalinich, W Murphy, KH Yu, F Wang, ...
Journal of the American Academy of Dermatology 86 (3), 563-572, 2022
602022
The system can't perform the operation now. Try again later.
Articles 1–20